Ci Investments Inc. Allogene Therapeutics, Inc. Transaction History

Ci Investments Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$3.17 - $5.96 $1,410 - $2,652	-445 Reduced 2.89%	14,936 $47,000
Q2 2023 Aug 11, 2023	BUY	$4.53 - $6.74 $29,417 - $43,769	6,494 Added 73.07%	15,381 $76,000
Q1 2023 May 12, 2023	SELL	$4.92 - $8.21 $565 - $944	-115 Reduced 1.28%	8,887 $44,000
Q4 2022 Feb 10, 2023	BUY	$5.62 - $11.11 $39,120 - $77,336	6,961 Added 341.06%	9,002 $57,000
Q3 2022 Nov 14, 2022	SELL	$10.32 - $17.28 $1,568 - $2,626	-152 Reduced 6.93%	2,041 $22,000
Q2 2022 Aug 12, 2022	BUY	$6.78 - $12.28 $6,630 - $12,009	978 Added 80.49%	2,193 $25,000
Q1 2022 May 12, 2022	BUY	$7.65 - $15.29 $9,294 - $18,577	1,215 New	1,215 $11,000

162

134M

59.4K

113K

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $326M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Ci Investments Inc. with notifications on news.